The following resources contain information regarding anthrax infection, guidelines regarding the prevention, treatment, and management of anthrax, external links to government organizations associated with the development and advancement of medical countermeasures, and publications of interest.
General Resources
Information about Inhalation Anthrax from the Centers for Disease Control and Prevention (CDC):

Definition and List of Bioterrorism Agents, by Category, published by the CDC:

Updated Guidelines on Prevention and Treatment of Anthrax in Adults (includes Medscape CME Activity for clinicians), published by the CDC:

Fact Sheet: “Biologic Attack: The Danger”, published the Department of Homeland Security:

Strategic National Stockpile – information from the United States Office of Public Health Preparedness and Response:


The Biotechnology Innovation Organization (BIO) –

BIO, Biodefense Policy Advisory Committee (BDPAC) – The Biodefense Policy Advisory Committee is made up of CEOs and division heads of companies working in the biodefense space. The committee advises BIO staff on policies to facilitate the biotechnology sector’s contribution to national preparedness, including federal funding for biodefense, biodefense procurement reform, authorized funding for advanced development projects, and strong federal pandemic influenza funding across an array of technologies to address near-term, mid-term, and long-term opportunities. Member companies include those developing vaccines, therapeutics, and diagnostics for use as medical countermeasures in the event of a natural, accidental, or man-made biological event.

Biomedical Advanced Research and Development Authority (BARDA) –

Medical Countermeasures –

US Food and Drug Administration, Emergency Preparedness & Response –

Centers for Disease Control and Prevention (CDC) –